Patient-controlled sedation with remimazolam during hip surgery
Part of Bones, joints & muscles, Pain clinical trials.
This trial tests if patients can safely control their own sedation during hip replacement surgery using a drug called remimazolam. The sedation is given through a patient-controlled pump, while spinal anesthesia keeps the surgical area numb.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 70 years old.
- You are having a first-time hip replacement surgery (primary hip arthroplasty).
- Your health is classified as ASA I or II (generally healthy or mild disease only).
- You are willing to be awake and may receive sedation during surgery.
- You have no allergies or bad reactions to remimazolam or similar drugs.
- Your alertness level is normal before surgery (MOAA/S score 5).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving flumazenil after remimazolam sedation can help people think more clearly after hip replacement surgery. If you are having a planned hip replacement and are generally healthy, this study might be for you.
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
This trial tests whether using remimazolam or propofol during hip or knee replacement surgery can lower the risk of postoperative delirium, a sudden, short-term confusion that can happen after anesthesia. It may help people who are at higher risk of postoperative confusion by finding the safer anesthesia approach.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
Hear when a new Hip Arthroplasty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.